<font color="red">Conscious_2</font> <font color="red">analgesia_2</font> <font color="red">/_2</font> <font color="red">sedation_2</font> <font color="red">with_2</font> <font color="red">remifentanil_2</font> <font color="red">and_2</font> <font color="red">propofol_2</font> versus <font color="red">total_1</font> <font color="red">intravenous_1</font> <font color="red">anesthesia_2</font> <font color="red">with_1</font> <font color="red">fentanyl_2</font> <font color="red">,_2</font> <font color="red">midazolam_2</font> <font color="red">,_2</font> <font color="red">and_1</font> <font color="red">propofol_2</font> for outpatient colonoscopy . 
<br>
<br> BACKGROUND This study tested the hypothesis that , for colonoscopy , <font color="red">analgesia_2</font> <font color="red">/_2</font> <font color="red">sedation_2</font> <font color="red">with_2</font> <font color="red">remifentanil_2</font> <font color="red">and_2</font> <font color="red">propofol_2</font> might be more effective compared with <font color="red">anesthesia_1</font> <font color="red">by_1</font> <font color="red">intravenous_1</font> <font color="red">administration_1</font> <font color="red">of_1</font> <font color="red">midazolam_2</font> <font color="red">,_2</font> <font color="red">fentanyl_2</font> <font color="red">,_2</font> <font color="red">and_1</font> <font color="red">propofol_2</font> <font color="red">._2</font> 
<br> METHODS In a prospective , randomized trial , 100 adult patients received either <font color="red">conscious_2</font> <font color="red">analgesia_2</font> <font color="red">/_2</font> <font color="red">sedation_2</font> ( Sedation group ) or <font color="red">total_2</font> <font color="red">intravenous_2</font> <font color="red">anesthesia_2</font> ( TIVA group ) . <font color="red">Analgesia_1</font> <font color="red">/_1</font> <font color="red">sedation_1</font> was achieved by infusion of <font color="red">remifentanil_1</font> ( 0.20 to 0.25 microg / kg / min ) and <font color="red">propofol_1</font> in titrated doses . <font color="red">TIVA_1</font> was induced by intravenous administration of <font color="red">fentanyl_1</font> ( 2 microg / kg ) , <font color="red">midazolam_1</font> ( 0.05 mg / kg ) and <font color="red">propofol_1</font> ( dosage titrated ) . Cardiorespiratory parameters and bispectral index were monitored and recorded . The quality of the analgesia was assessed with a Numerical Pain Rating Scale ( NRS ) ; recovery level and return of psychomotor efficiency were evaluated with , respectively , the Aldrete scale and a Modified Post Anesthesia Discharge Scoring ( MPADS ) system . 
<br> RESULTS Both groups of 50 patients were comparable with respect to demographic data , initial parameters , and duration of colonoscopy . All patients in the <font color="red">TIVA_1</font> group found the colonoscopy painless ( NRS score 0 ) . In the <font color="red">Sedation_1</font> group , the average pain intensity score was 0.4 ( 0.8 ) . There was a marked difference between the <font color="red">Sedation_1</font> and <font color="red">TIVA_1</font> groups with respect to the time from the end of the procedure until the maximum MPADS score was reached : respectively , -6.9 ( 4.0 ) versus 25.7 ( 8.4 ) minutes ( p < 0.001 ) . In the <font color="red">TIVA_1</font> group , changes in mean arterial pressure and heart rate and signs of respiratory depression were significant ( p < 0.05 ) . 
<br> CONCLUSIONS <font color="red">Combined_1</font> <font color="red">administration_1</font> <font color="red">of_1</font> <font color="red">remifentanil_2</font> <font color="red">and_1</font> <font color="red">propofol_2</font> for colonoscopy provides sufficient analgesia , satisfactory hemodynamic stability , minor respiratory depression , and rapid recovery , and allows patients to be discharged approximately 15 minutes after the procedure .